Stem Cells SpinS.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2011-02-09
Share capital
7 833 650,00 PLN
Registered address
Teofila Lenartowicza 6, 51-140 Wrocław, Poland
Website
stemcellsspin.com.plWebsite active
Electronic delivery address
AE:PL-44979-36099-SRVAV-27

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Stock quotes

PLN 0.46
0.00 (0.00%)
0.460.470.480.490.4610:0012:0014:0016:00
Open
PLN 0.46
High
PLN 0.46
Low
PLN 0.46
Volume
150
Avg. vol.
318.9
Market cap
PLN 19.01M
P/E ratio
–
EPS
-PLN 0.02
Shares outstanding
41.34M
52-week
PLN 0.46 – 0.50
Dividend yield
–
Dividend
–
Ex dividend date
–
ISIN
PLSTCLS00013
Exchange
NewConnect

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 4.86kUSD -41.60kUSD -41.60k
Q1 2026USD 1.89kUSD -45.11kUSD -45.11k
Q4 2025USD 8.29kUSD -36.41kUSD -36.41k
Q3 2025USD 6.28kUSD -29.13kUSD -29.38k

Results for Q3 2026:Nov 16, 2026

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 287.71kMedianUSD 782.27kAverageUSD 24.03m
Net profit
This companyUSD -132.00kMedianUSD 7.91kAverageUSD 2.59m
Operating costs
This companyUSD 417.72kMedianUSD 723.93kAverageUSD 19.92m
Assets
This companyUSD 2.40mMedianUSD 800.34kAverageUSD 29.11m

Industry

Bank accounts

Registered as a VAT taxpayer on 2009-04-08. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Buildings and premises
PLN 2,422

Public aid

10 public aid cases recorded, with a total value of $556,898.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–

European Funds

ProjectEU co-financing
Opracowanie hydrożelu z zawartością homogenatu porożogennych komórek macierzystych o działaniu neuroprotekcyjnym dla tkanki rdzenia kręgowego
$510.8K

Tenders

No recorded participation in tenders.

Trademarks

Stem Cells Spin holds 1 active trademark registered with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2010.

MarkProtected until
revitacell(word)Oct 7, 2031
revitacell–
Stem Cells Spin–
Velvetyna–
biocervin–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Adam Symber – Vice President of the Management Board
Magdalena Cegielska – President of the Management Board
Wojciech Grzegorczyk – Attorney-in-fact (joint)

Manner of representation

One member of the management board is authorized to submit declarations of will on behalf of the company and to represent it in the case of a one-person management board, or two members of the management board jointly or a member of the management board jointly with a commercial proxy in the case of a multi-member management board.

Supervisory board

Marek Andrzej Cegielski – Supervisory Board Member
Andrzej Trznadel – Supervisory Board Member
Tomasz Gębarowski – Supervisory Board Member
Joanna Holanowska – Supervisory Board Member
Piotr Okoniewski – Supervisory Board Member

Beneficial owners

No beneficial owners recorded for the company Stem Cells Spin.

Competitors

Name
Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o.
Biomarsp. z o.o.
Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o.
Human BiomeS.A.
Zeptor Polskasp. z o.o.
F1 PharmaS.A.
Ti-Comsp. z o.o.
LideoS.A.
Munar PharmaS.A.
Ampliconsp. z o.o.

Change history

DateEvent
2026-09-17Share capital change
2018-07-23Share capital change
2015-04-23PKD change
2015-03-10PKD change
2014-01-13Share capital change

FAQ

Last updated: 2026-09-17